Live Breaking News & Updates on Pharmalex Gmbh

Stay updated with breaking news from Pharmalex gmbh. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Defence Therapeutics Inc.: Defence Therapeutics Signs an Agreement with Biopharma Excellence, a Pharmalex GmbH Company, to Maximize and Strategize the Development of Its Accum Platform and Clinical Trials


Defence Therapeutics Inc.: Defence Therapeutics Signs an Agreement with Biopharma Excellence, a Pharmalex GmbH Company, to Maximize and Strategize the Development of Its Accum Platform and Clinical Trials
Defence or the
Company ), a biotechnology company working on cancer therapeutics and infectious disease vaccines is pleased to announce the agreement with the German renowned pharmaceutical consulting and advisory company, Pharmalex GmbH, through Biopharma Excellence.
With more than 35,000 successful projects completed, Pharmalex GmbH is a leading provider of specialized services for the pharmaceuticals, biotech and medical device industries that prioritize compliance. Biopharma Excellence, a Pharmalex GmbH division, is a leading pharmaceutical consultancy company with expertise covering all areas from development to approval and partnering of biopharmaceuticals with a focus on Europe, United States and Japan regulatory affairs. ....

United States , United Kingdom , City Of , British Columbia , Michael Pfleiderer , Sebastien Plouffe , Pharmalex Gmb , Vaccine Working Party , Collaborative Center , Defence Therapeutics Inc , Regulatory Affairs , Member Of The Biologics Working Party , British Columbia Newsfile Corp , Pandemic Task Force , German Federal Institute For Vaccines , European Medicines Agency , Head Of The World Health Organization , Committee For Medicinal Products Human Use , Pharmalex Gmbh , Biopharma Excellence , Lead Scientist , Human Viral Vaccines Section , German Federal Institute , Principal Consultant , Medicinal Products , Human Use ,

PharmaLex acquires majority interest in Brandwood CKC

PharmaLex acquires majority interest in Brandwood CKC By Jerome Doraisamy|24 May 2021 Hall & Wilcox has advised PharmaLex GmbH on acquiring a majority interest in an Australian health science consultancy. Advertisement ); googletag.cmd.push(function() { googletag.display( div-gpt-ad-1606778613657-0 ); }); } Advertisement Deal: International medical technology consultancy PharmaLex GmbH has acquired a majority interest in Australian health science consultancy Brandwood CKC. Hall & Wilcox advised on the due diligence, assisted with drafting and negotiating all transaction documents, and provided regulatory advice. Value: Undisclosed. Area: Corporate. Key players: The Hall & Wilcox team was led by partner Oliver Jankowsky, who was assisted by senior associate Chevi Levin and lawyer David Holland, as well as partner Alison Choy Flannigan and senior associate Jeanette Lui. ....

David Holland , Jeanette Lui , Oliver Jankowsky , Chevi Levin , Jerome Doraisamy , Pharmalex Gmb , Hall Wilcox , Pharmalex Gmbh , Alison Choy Flannigan , Auctus Capital Partners , டேவிட் ஹாலண்ட் , ஜீனெட் லு , செவி லெவின் , மண்டபம் வில்காக்ஸ் , அலிசன் சோய் ப்ளன்னிகன் , ஆசிட்ஸ் மூலதனம் கூட்டாளர்கள் ,